Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More
Xconomy
OCTOBER 7, 2016
PRICE FIGHTS. With some caveats, ICER recommended lower prices. —Merrimack Pharmaceuticals (NASDAQ: MACK ) announced layoffs of 22 percent of its staff and the resignation of CEO Robert Mulroy. . —The Nobel in Chemistry went to three scientists, in France, the Netherlands, and the U.S., CLINICAL NEWS.
Let's personalize your content